MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |
SILVERARC CAPITAL MANAGEMENT, LLC | 801,600 | $1,018,032 | 0.31% |
DAFNA Capital Management LLC | 734,038 | $932,228 | 0.29% |
Ikarian Capital, LLC | 1,579,770 | $2,006,308 | 0.24% |
Newtyn Management, LLC | 700,000 | $889,000 | 0.22% |
Boxer Capital, LLC | 2,000,000 | $2,540,000 | 0.14% |
Rock Springs Capital Management LP | 3,403,133 | $4,321,979 | 0.12% |
Bellevue Group AG | 5,218,625 | $6,627,654 | 0.11% |
Sarissa Capital Management LP | 550,000 | $698,500 | 0.09% |
Atom Investors LP | 293,177 | $372,335 | 0.08% |
ACUTA CAPITAL PARTNERS, LLC | 99,607 | $126,501 | 0.08% |
External links
This page lists MERSANA THERAPEUTICS INC's shareholders in Q3 2023. To view MERSANA THERAPEUTICS INC's shareholder history, click here.